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Abstract
Both direct potentiometry and indirect potentiometry are currently used for Na+ testing in blood. These measurement
techniques show good agreement as long as protein and lipid concentrations in blood remain normal. In severely ill patients,
indirect potentiometry commonly leads to relevant errors in Na+ estimation: 25% of specimens show a disagreement between
direct and indirect potentiometry, which is ≥4 mmol/L (mostly spuriously elevated Na+ level due to low circulating albumin
concentration). There is a need for increased awareness of the poor performance of indirect potentiometry in some clinical
settings.
Dysnatraemias sometimes result in major neurologic complica-
tions [1, 2]. On the other hand, improper ﬁxing may also cause
neurologic damage [3]. Recent observations published [1] and com-
mentedon [2] in this journal conﬁrm thepooraccuracyof equations
thathavebeenproposed topredict the responseof bloodNa+ values
to intravenous ﬂuids. It is therefore concluded that when ﬁxing the
Na+ level, physicians should test this ion often [1, 2].
Potentiometric sensors, whose key component is an ion-
selective electrode, are currently used for Na+ testing [3, 4]. Direct
potentiometry, which does not require sample dilution prior to
measurement, is employed in point-of-care blood-gas analysers,
while indirect potentiometry, which requires sample dilution
prior to measurement, is utilized in main laboratory analysers.
Direct and indirect potentiometry show good agreement as
long as protein and lipid concentrations in blood remain normal
[3–5]. When Na+ is measured by indirect potentiometry, in-
creased protein or lipid concentration results in spuriously low
Na+ (pseudo-hyponatraemia) whereas decreased protein (mostly
albumin) or lipid concentration results in spuriously high Na+
(pseudo-hypernatraemia). A spuriously normal value (pseudo-
normonatraemia) in a patient with true hyponatraemia or
hypernatraemia may also occur: pseudo-normonatraemia may
be found either in a patient with true hyponatraemia and de-
creased albumin concentration or in a patient with true hyperna-
traemia and increased protein or lipid concentration [4, 5]. In
severely ill patients [5], indirect potentiometry commonly leads
to relevant errors in Na+ estimation: 25% of specimens show a
disagreement between direct and indirect potentiometry that is
≥4 mmol/L (most frequently spuriously elevated Na+ level due
to low circulating protein concentration); for each 10 g/L rise or
fall in albumin [6], there is a fall or a rise in Na+ level of
∼2 mmol/L (impact of albumin ismuch greater than that of lipids
owing to the wider absolute range of albumin values observed in
the clinical setting).
Discrepancies in Na+ level resulting in suboptimal manage-
ment may be seen when Na+ is monitored using a combination
of point-of-care analysers andmain laboratory analysers [7]. Un-
surprisingly, therefore, the European Society of Endocrinology,
the European Society of Intensive Care Medicine and the Euro-
peanRenal Association – EuropeanDialysis and Transplant Asso-
ciation recommend that the diagnosis of dysnatraemia should be
based on testing by direct potentiometry [3].
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In conclusion, altered lipid and, by far more frequently, al-
tered protein levels can have a clinically relevant effect on the re-
sults obtained from the laboratory analysers compared with the
point-of-care analysers [3–5]. Clinicians should be aware of these
differences and utilize exclusively a single type of measurement.
Finally, many authorities, including the International Federation
of Clinical Chemistry and Laboratory Medicine, recommend that
the indirect technology is gradually abandoned [4].
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